Stock Research for HAE

Featured Broker: Ally Invest

Get the due diligence for another stock.


HAE Stock Chart & Research Data

The HAE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the HAE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


HAE Due diligence Resources & Stock Charts

The HAE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View HAE Detailed Price Forecast - CNN Money CNN View HAE Detailed Summary - Google Finance
Yahoo View HAE Detailed Summary - Yahoo! Finance Zacks View HAE Stock Research & Analysis -

Stock Analysis

TradeIdeas View HAE Trends & Analysis - Trade-Ideas Barrons View HAE Major Holders - Barrons
NASDAQ View HAE Call Transcripts - NASDAQ Seeking View HAE Breaking News & Analysis - Seeking Alpha
Spotlight View HAE Annual Report - OTC Report View HAE OTC Short Report -
TradeKing View HAE Fundamentals - TradeKing Charts View HAE SEC Filings - Bar Chart
WSJ View Historical Prices for HAE - The WSJ Morningstar View Performance/Total Return for HAE - Morningstar
MarketWatch View the Analyst Estimates for HAE - MarketWatch CNBC View the Earnings History for HAE - CNBC
StockMarketWatch View the HAE Earnings - StockMarketWatch MacroAxis View HAE Buy or Sell Recommendations - MacroAxis
Bullish View the HAE Bullish Patterns - American Bulls Short Pains View HAE Short Pain Metrics -

Social Media Mentions

StockTwits View HAE Stock Mentions - StockTwits PennyStocks View HAE Stock Mentions - PennyStockTweets
Twitter View HAE Stock Mentions - Twitter Invest Hub View HAE Investment Forum News - Investor Hub
Yahoo View HAE Stock Mentions - Yahoo! Message Board Seeking Alpha View HAE Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for HAE - Insider Cow View Insider Transactions for HAE - Insider Cow
CNBC View HAE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for HAE - OTC Markets
Yahoo View Insider Transactions for HAE - Yahoo! Finance NASDAQ View Institutional Holdings for HAE - NASDAQ

Stock Charts

FinViz View HAE Stock Insight & Charts - StockCharts View HAE Investment Charts -
BarChart View HAE Stock Overview & Charts - BarChart Trading View View HAE User Generated Charts - Trading View

Latest Financial News for HAE

Free Pre-Market Technical Recap on Hologic and Three Additional Medical Supplies Stocks
Posted on Wednesday July 11, 2018

On Tuesday, July 10, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Seven out of nine sectors ended Tuesday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, assessed the following Medical Instruments & Supplies equities this morning: Becton, Dickinson and Co. (NYSE: BDX), Ekso Bionics Holdings Inc. (NASDAQ: EKSO), Haemonetics Corp. (NYSE: HAE), and Hologic Inc. (NASDAQ: HOLX).

Why HAE’s Blood Center Business Could See Small Revenue Decline
Posted on Thursday June 28, 2018

Haemonetics (HAE) expects its blood center business to report a year-over-year (or YoY) revenue decline in the range of 3% to 6% in fiscal 2019, resulting from a gradual decline in the rate of transfusions and from the rising market share of its competitor’s double-dose platelet-collection technology in Japan. The blood center business is proving to be a challenge for Haemonetics, while the company competes with other medical device players such as Medtronic (MDT), Abbott Laboratories (ABT), and Stryker (SYK) for investor dollars. The above diagram highlights the distribution of revenues across various segments in Haemonetics’s blood center business in the first three quarters of fiscal 2018.

Commercial Launch of NexSys PCS May Boost Haemonetics’s Revenues
Posted on Thursday June 28, 2018

On March 28, 2018, the FDA approved an enhancement to Haemonetics’s (HAE) NexSys PCS embedded software, which will activate a yield-enhancing solution based on YES technology to improve the total plasma yield per collection. While the NexSys PCS device was already approved by the FDA in July 2017, the recent approval has enabled the company to initiate discussions with customers about the value proposition of its integrated plasma collection platform consisting of NexSys PCS, NesLynk DMS Donor Management Software, other disposables, and technical support services. Haemonetics is involved in ensuring that its internal manufacturing capabilities don’t fall short of the customer demand for NexSys PCS.

New Research Coverage Highlights Knowles, Advaxis, G-III Apparel Group, LTD, National CineMedia, Haemonetics, and MACOM Technology Solutions — Consolidated Revenues, Company Growth, and Expectations for 2018
Posted on Thursday June 28, 2018

NEW YORK, June 28, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Knowles ...

Enter a stock symbol to view the stock details.